Viewing Study NCT06937905


Ignite Creation Date: 2025-12-25 @ 3:16 AM
Ignite Modification Date: 2026-01-12 @ 6:02 AM
Study NCT ID: NCT06937905
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-04-22
First Post: 2025-04-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Tarlatamab vs Standard of Care Chemotherapy in Patients With Pre-treated Advanced, Pulmonary or Gastroenteropancreatic Poorly Differentiated Neuroendocrine Carcinomas (NECs)
Sponsor: Intergroupe Francophone de Cancerologie Thoracique
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module